Sangamo has performance score of 2 on a scale of 0 to 100. The firm has beta of 1.81 which indicates as market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Sangamo will likely underperform. Although it is extremely important to respect Sangamo Biosciences
current price movements, it is beter to be realistic about what you can do with the information about equity historical returns. The philosophy towards measuring future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators
. By inspecting Sangamo Biosciences technical indicators
you can presently evaluate if the expected return of 0.12% will be sustainable into the future. Sangamo Biosciences
right now has risk of 2.88%. Please validate Sangamo Value At Risk
as well as the relationship
and Day Median Price
to decide if Sangamo will be following its existing price patterns
Relative Risk vs. Return Landscape
If you would invest 784
in Sangamo Biosciences Inc on May 19, 2013
and sell it today you would earn a total of 15.00
from holding Sangamo Biosciences Inc or generate 1.91%
return on investment over 30
days. Sangamo Biosciences Inc is currenly generating 0.12% of daily expected returns and assumes 2.88% risk (volatility on return distribution) over the 30 days horizon. In different words, 35% of equities are less volatile than Sangamo Biosciences Inc and 95% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
Daily Expected Return (%)
Given investment horizon of 30 days, Sangamo Biosciences Inc is expected to generate 3.43 times more return on investment than the market. However, the company is 3.43 times more volatile than its market benchmark. It trades about 0.04 of its potential returns per unit of risk. The S&P 500 is currently generating roughly -0.1 per unit of risk.
Sangamo Operating Margin
Based on recorded statements Sangamo Biosciences Inc has Operating Margin of -94.72%. This is 230.61% higher than that of Healthcare sector, and 5.2% lower than that of Biotechnology
industry, The Operating Margin for all stocks is 2341.24% higher than the company.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.
Sangamo Return On Equity vs Return On Asset
Sangamo Biosciences Inc is rated below average
in return on equity category among related companies. It is rated below average
in return on asset category among related companies .